Neurocysticercosis. An emergent disease;Neurocisticercosis. Una enfermedad emergente

Anales del Sistema Sanitario de Navarra

Volumn 27, Issue 2, 2004, Pages 201-209

  Imirizaldu, Lorea ^a   Miranda, L ^a   Garcia Gurtubay I ^a   Gaston I ^a   Urriza, J ^a   Quesada, P ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Albendazole; Crisis; Immigration; Neurocysticerosis; Taenia solium

Indexed keywords

ALBENDAZOLE;

CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; HEADACHE; HUMAN; HYGIENE; IMMIGRATION; IMMUNOLOGY; INCIDENCE; NEUROCYSTICERCOSIS; NEUROIMAGING; NONHUMAN; REVIEW; SEIZURE; TAENIA SOLIUM;

DIAGNOSIS, DIFFERENTIAL; HUMANS; NEUROCYSTICERCOSIS; PROGNOSIS;

EID: 4544281911     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. PÉREZ-LÓPEZ C, ISLA-GUERRERO A, ÁLVAREZ F, BUDKE M, FERNÁNDEZ-MIRANDA JC, PAZ JF et al. Actualizatión en el tratamiento de la neurocisticercosis. Rev Neurol 2003; 36: 805-811.
2. DUMAS JL, VISY JM, BELIN C, GASTON A, GOLDLUST D, DUMAS M. Parenchymal neurocysticercosis: follow-up and staging by MRI. Neuroradiology 1997; 39; 12-18.
3. GILMAN RH, DEL BRUTTO OH, GARCÍA HH, MARTÍNEZ M. Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. Neurology 2000; 55: 1062.
4. GlMĖNEZ-ROLDȦN S, DİAZ F, ESQUIVEL A. Neurocisticercosis e inmigración. Neurología 2003; 18: 385-388.
5. GARCÍA HH, GONZȦLEZ AE, EVANS CAW, GILMAN RH. Taenia solium cysticercosis. Lancet 2003; 362: 547-556.
6. GARCÍA HH, DEL BRUTTO OH. Taenia solium cysticercosis. Infect Dis Clin North Am 2000; 14: 97-119.
7. CARPIO A, HAUSER WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002; 59: 1730-1734.
8. DEL BRUTTO OH. Neurocisticercosis. Rev Neurol 1999; 29: 456-466.
9. PAL DK, CARPIO A, SANDER JWAS. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000; 68: 137-143.
10. WHITE AC JR. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis and management. Ann Rev Med 2000; 51: 187-206.
11. TERRAZA S, PUJOL T, GASCON J, CORACHAN M. Neurocisticercosis: ¿una enfermedad importada? Med Clin (Bare) 2001; 116: 261-263.
12. SANZ CR. Host response in childhood neurocysticercosis: some pathological aspects. Child Nerv Syst 1987; 3: 206-207.
13. SALGADO P, ROJAS R, SOTELO J. Cysticercosis. Clinical classification based on imaging studies. Arch Intern Med 1997; 157: 1991-1997.
14. DEL BRUTTO OH, SANTIBAÑEZ R, NOBOA CA, AGUIRRE R, DÍAZ E. ALARCÓN TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992; 42: 389-392.
15. CARPIO A, ESCOBAR A, HAUSER AW Cysticercosis and epilepsy: a critical review. Epilepsia 1998; 39: 1025-1040.
16. DEL BRUTTO OH. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 1994; 44: 1706-1709.
17. DEL BRUTTO OH, RAJSHEKHAR V, WHITE AC JR, TSANG VC, NASH TE, TAKAYANAGUI OM et al. Proposed diagnostic criteria for neurocisticercosis. Neurology 2001; 57: 177-183.
18. OSBORN AG. Enfermedades del encéfalo y sus cubiertas. En: Neurorradiología diagnóstica. Harcourt-Brace. Madrid 1996: 709-712.
19. ROMERO FJ. Patología infecciosa e inflamatoria del SNC. En: Neuroimagen clínica. Arán 1999: 268-272.
20. Ciclo biológico de la Taenia solium. http://mnemonica.org /docs/patologia/Neurocisticercosis.doc.
21. CARPIO A, SANTILLÁN F, LEÓN P, FLORES C, HAUSER A. Is the course of neurocysticercosis modified by treatment with antihelmintic agents? Arch Intern Med 1995; 155: 1982-1988.
22. LOBATO RD, LAMAS E, PORTILLO JM, ROGER J, ESPARZA J, RIVAS JJ et al. Hydrocephalus in cerebral cisticercosis. Pathogenic and therapeutic considerations. J Neurosurg 1981; 55: 786-793.
23. CARPIO A. Neurocysticercosis: an update. Lancet. Infect Dis 1999; 2: 751-762.
24. ANTONIUK S. Epidemiología de la neurocisticercosis. Rev Neurol 1999; 29: 331-334.